Drugs / AFOLIA
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT02459418 | May 2015 → May 2016 | — | Fertility Biotech AG | Completed | No outcome recorded |
| Phase 1 | NCT01141270 | Jan → Aug 2009 | — | Polymun Scientific GmbH | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT01687712 | Nov 2013 → Sep 2015 | infertility disorder | Fertility Biotech AG | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Afolia | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02459418 ↗ |
| Route | Subcutaneous | “single sc injection, 225 IU” NCT01141270 ↗ |